Pharma Reviews: Indian drug makers to focus on inorganic growth, US remains key market: Moody's

In the next 18-24 months, the US generic drugs market may grow around 10%, supported by $20-25 billion worth of branded drugs going off patent ...
Read more: Indian drug makers to focus on inorganic growth, US remains key market: Moody's